Global Minimally Invasive Spine Surgery Market Size Likely to Surpass at a CAGR of 7.1% By 2033

As per the current market research conducted by the CMI Team, the global Minimally Invasive Spine Surgery Market size is expected to record a CAGR of 7.1% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 2,590.2 Million. By 2033, the valuation is anticipated to reach USD 4,802.2 Million.

Minimally Invasive Spine Surgery Market: Growth Factors and Dynamics

• Technological Advancements: Ongoing innovations in surgical techniques, instruments, and imaging technologies have enhanced the safety, efficacy, and precision of minimally invasive spine surgeries, driving market growth.

• Reduced Surgical Trauma: Minimally invasive spine surgeries involve smaller incisions, leading to reduced tissue damage, blood loss, post-operative pain, and shorter hospital stays, contributing to the increasing adoption of these procedures.

• Growing Aging Population: The rising prevalence of age-related spine disorders, such as degenerative disc disease and spinal stenosis, among the aging population drives the demand for minimally invasive spine surgeries as a preferred treatment option, fueling the market growth.

• Increasing Patient Awareness: Growing patient awareness of the benefits of minimally invasive spine surgery, including quicker recovery, reduced scarring, and lower risk of complications, is driving patient preference and demand for these procedures.

• Expanding Indications: The expansion of indications for minimally invasive spine surgery beyond traditional procedures, such as lumbar discectomy and fusion, to include complex surgeries like deformity correction and tumor resection, broadens the market scope and drives procedure volumes.

• Reimbursement Support: Favorable reimbursement policies and increased insurance coverage for minimally invasive spine surgeries in various regions support patient access to these procedures, driving market growth and adoption rates.

• Shift towards Outpatient Settings: The increasing trend towards outpatient minimally invasive spine surgeries, facilitated by advancements in surgical techniques and anesthesia, reduces healthcare costs and improves patient convenience, driving the market growth.

• Regulatory Support and Guidelines: Stringent regulatory standards and guidelines governing the safety and efficacy of minimally invasive spine surgery devices and procedures ensure quality assurance and patient safety, fostering market growth by instilling confidence among healthcare providers and patients.

• Emerging Markets Adoption: Emerging economies witnessing rapid urbanization and healthcare infrastructure development are increasingly adopting minimally invasive spine surgery techniques. This adoption is driven by the rising burden of spine disorders, improving healthcare access, and growing investments in medical technology.

Minimally Invasive Spine Surgery Market: Partnership and Acquisitions

• In 2023, Stryker’s Q Guidance System, approved by the US FDA for cranial applications, enhances precision and safety in cranial surgeries. This advanced system offers surgeons real-time guidance and navigation capabilities, improving surgical outcomes and patient care in neurosurgical procedures.

• In 2022, Nexus Spine unveiled its Stable-C cervical interbody fusion implants, incorporating integrated anchoring blades. This advancement in biomechanically advanced solutions for spinal pathologies aims to improve stability and fusion outcomes in cervical spine surgeries, enhancing patient care and surgical efficacy.

Report Scope

Minimally Invasive Spine Surgery Market: COVID-19 Analysis

The COVID-19 pandemic has significantly impacted the Minimally Invasive Spine Surgery Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

• Disruption of Elective Procedures: During the COVID-19 pandemic, many hospitals postponed elective surgeries, including minimally invasive spine surgeries, to prioritize resources for COVID-19 patients, leading to a decline in procedure volumes and revenue for spine surgery providers.

• Supply Chain Disruptions: Disruptions in the global supply chain due to lockdown measures and trade restrictions affected the availability of surgical instruments, implants, and medical devices required for minimally invasive spine surgeries, impacting procedure scheduling and patient care.

• Resumption of Elective Surgeries: As COVID-19 cases decline and healthcare facilities resume elective procedures, including minimally invasive spine surgeries, pent-up demand for these surgeries is expected to drive procedure volumes and revenue recovery.

• Implementation of Safety Protocols: Healthcare facilities are implementing stringent safety protocols, such as preoperative COVID-19 testing, enhanced disinfection measures, and personal protective equipment (PPE) requirements, to ensure the safety of patients and healthcare workers during minimally invasive spine surgeries.

• Telemedicine and Remote Consultations: The adoption of telemedicine and remote consultations allows spine surgeons to conduct preoperative assessments, postoperative follow-ups, and patient consultations remotely, reducing the need for in-person visits and minimizing the risk of COVID-19 transmission.

• Focus on Outpatient Procedures: Healthcare facilities are increasingly performing minimally invasive spine surgeries on an outpatient basis, allowing patients to undergo surgery and return home on the same day, thereby reducing the risk of exposure to COVID-19 in healthcare settings and improving patient throughput.

• Innovation and Technology Adoption: Spine surgery providers are investing in innovative technologies, such as robotic-assisted surgery systems and navigation systems, to enhance the efficiency, accuracy, and safety of minimally invasive spine surgeries, driving market recovery and growth post-pandemic.

• Patient Education and Engagement: Healthcare providers are prioritizing patient education and engagement initiatives to address patient concerns and build trust in the safety and efficacy of minimally invasive spine surgeries amid the COVID-19 pandemic. These initiatives include educational materials, virtual seminars, and online forums to inform patients about the benefits, risks, and precautions associated with spine surgery.

In conclusion, the COVID-19 pandemic has had a mixed impact on the Minimally Invasive Spine Surgery Market, with some challenges and opportunities arising from the pandemic.

List of the prominent players in the Minimally Invasive Spine Surgery Market:

• Medtronic plc
• NuVasive Inc.
• Stryker Corporation
• Zimmer Biomet Holdings Inc.
• Globus Medical Inc.
• DePuy Synthes (Johnson & Johnson)
• Braun Melsungen AG
• MicroPort Scientific Corporation
• Aesculap Implant Systems LLC
• Alphatec Holdings Inc.
• RTI Surgical Holdings Inc.
• Orthofix Medical Inc.
• K2M Group Holdings Inc.
• SeaSpine Holdings Corporation
• CoreLink LLC
• Others

The Minimally Invasive Spine Surgery Market is segmented as follows:

By Product

• Implants & instrumentation
• Biomaterials

By Application

• Fusion Surgery
• Non-fusion Surgery

By Treatment

• Lumbar Disc Herniation
• Thoracic Disc Herniation
• Spinal Stenosis
• Degenerative Spinal Disease
• Others

By End Users

• Hospitals and Clinics
• Home Care Settings
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America